Search Reports
Categories
Categories

Global Endorphins Market

Global Endorphins Market Research Report 2024(Status and Outlook)

Report Code : PHA1732
Published Date : 05 December, 2024 | No of Pages: 134

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Endorphins, often referred to as the body\'s natural painkillers, are neurotransmitters produced by the central nervous system and the pituitary gland. They are known to reduce pain and induce feelings of pleasure or euphoria. The market for endorphins is a niche segment within the broader pharmaceutical and wellness industries, primarily focusing on products or services that stimulate endorphin production or mimic their effects.

As of 2023, the global market size for endorphins stands at approximately USD 85 million. The market is projected to grow at a compound annual growth rate (CAGR) of 7.80% from 2024 to 2032. This growth can be attributed to several key factors driving the market forward.

One of the primary growth drivers for the endorphins market is the increasing awareness of mental health and well-being. As more individuals seek natural ways to manage stress, anxiety, and pain, the demand for endorphin-boosting products and services is on the rise. Additionally, the growing preference for holistic approaches to health and wellness is fueling the adoption of activities such as exercise, meditation, and acupuncture, all of which can stimulate endorphin release.

Moreover, advancements in biotechnology and neuroscience are leading to the development of innovative endorphin-related products. For instance, pharmaceutical companies are investing in research to create new drugs that target endorphin receptors for pain management. Similarly, the rise of personalized medicine is driving the customization of endorphin-based therapies to cater to individual needs.

In terms of market trends, there is a noticeable shift towards natural and sustainable endorphin-boosting solutions. Consumers are increasingly gravitating towards organic products, such as herbal supplements or essential oils, that promote endorphin release without synthetic chemicals. Furthermore, the integration of technology in wellness offerings, such as wearable devices that track endorphin levels during physical activity, is gaining traction among tech-savvy consumers.

Regionally, North America and Europe currently dominate the endorphins market due to high healthcare spending, strong research and development capabilities, and a well-established wellness industry. In these regions, factors like increasing chronic pain conditions, rising mental health awareness, and a growing aging population contribute to market growth. However, Asia-Pacific is emerging as a lucrative market for endorphins, driven by the rising disposable income, expanding healthcare infrastructure, and a shifting focus towards preventive healthcare practices.

Despite the promising growth prospects, the endorphins market faces challenges such as regulatory hurdles in drug development, limited awareness among consumers about endorphin-related therapies, and the presence of alternative pain management solutions in the market. Overcoming these challenges will require industry players to invest in education campaigns, forge strategic partnerships with healthcare providers, and navigate the complex regulatory landscape to bring innovative endorphin-based products to market.

In conclusion, the global endorphins market is poised for steady growth fueled by increasing health consciousness, technological advancements, and shifting consumer preferences towards natural remedies. By capitalizing on these trends and addressing key challenges, stakeholders in the endorphins market can unlock new opportunities for product development, market expansion, and improved patient outcomes.
This report provides a deep insight into the global Endorphins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endorphins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endorphins market in any manner.
Global Endorphins Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson

Market Segmentation (by Type)
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins

Market Segmentation (by Application)
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Endorphins Market
• Overview of the regional outlook of the Endorphins Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endorphins Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Endorphins
      1.2 Key Market Segments
            1.2.1 Endorphins Segment by Type
            1.2.2 Endorphins Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Endorphins Market Overview
      2.1 Global Market Overview
            2.1.1 Global Endorphins Market Size (M USD) Estimates and Forecasts (2019-2032)
            2.1.2 Global Endorphins Sales Estimates and Forecasts (2019-2032)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
      2.4 Macroeconomic Analysis
  3 Endorphins Market Competitive Landscape
      3.1 Global Endorphins Sales by Manufacturers (2019-2024)
      3.2 Global Endorphins Revenue Market Share by Manufacturers (2019-2024)
      3.3 Endorphins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.4 Global Endorphins Average Price by Manufacturers (2019-2024)
      3.5 Manufacturers Endorphins Sales Sites, Area Served, Product Type
      3.6 Endorphins Market Competitive Situation and Trends
            3.6.1 Endorphins Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Endorphins Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Endorphins Industry Chain Analysis
      4.1 Endorphins Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Endorphins Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Market Restraints
      5.5 Industry News
            5.5.1 New Product Developments
            5.5.2 Mergers & Acquisitions
            5.5.3 Expansions
            5.5.4 Collaboration/Supply Contracts
      5.6 Industry Policies
  6 Endorphins Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Endorphins Sales Market Share by Type (2019-2024)
      6.3 Global Endorphins Market Size Market Share by Type (2019-2024)
      6.4 Global Endorphins Price by Type (2019-2024)
  7 Endorphins Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Endorphins Market Sales by Application (2019-2024)
      7.3 Global Endorphins Market Size (M USD) by Application (2019-2024)
      7.4 Global Endorphins Sales Growth Rate by Application (2019-2024)
  8 Endorphins Market Sales by Region
      8.1 Global Endorphins Sales by Region
            8.1.1 Global Endorphins Sales by Region
            8.1.2 Global Endorphins Sales Market Share by Region
      8.2 Global Endorphins Market Size by Region
            8.2.1 Global Endorphins Market Size by Region
            8.2.2 Global Endorphins Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Endorphins Sales by Country
            8.3.2 North America Endorphins Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Endorphins Sales by Country
            8.4.2 Europe Endorphins Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Russia Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Endorphins Sales by Region
            8.5.2 China
            8.5.3 Japan
            8.5.4 South Korea
            8.5.5 India
            8.5.6 Southeast Asia
      8.6 Asia Pacific
            8.6.1 Asia Pacific Endorphins Market Size by Region
            8.6.2 Asia Pacific Endorphins Market Size by Region
            8.6.3 China
            8.6.4 Japan
            8.6.5 South Korea
            8.6.6 India
            8.6.7 Southeast Asia
      8.7 South America
            8.7.1 South America Endorphins Sales by Country
            8.7.2 South America Endorphins Market Size by Country
            8.7.3 Brazil
            8.7.4 Argentina
            8.7.5 Columbia
      8.8 Middle East and Africa
            8.8.1 Middle East and Africa Endorphins Sales by Region
            8.8.2 Middle East and Africa Endorphins Market Size by Region
            8.8.3 Saudi Arabia
            8.8.4 UAE
            8.8.5 Egypt
            8.8.6 Nigeria
            8.8.7 South Africa
  9 Endorphins Market Production by Region
      9.1 Global Production of Endorphins by Region (2019-2024)
      9.2 Global Endorphins Revenue Market Share by Region (2019-2024)
      9.3 Global Endorphins Production, Revenue, Price and Gross Margin (2019-2024)
      9.4 North America Endorphins Production
            9.4.1 North America Endorphins Production Growth Rate (2019-2024)
            9.4.2 North America Endorphins Production, Revenue, Price and Gross Margin (2019-2024)
      9.5 Europe Endorphins Production
            9.5.1 Europe Endorphins Production Growth Rate (2019-2024)
            9.5.2 Europe Endorphins Production, Revenue, Price and Gross Margin (2019-2024)
      9.6 Japan Endorphins Production (2019-2024)
            9.6.1 Japan Endorphins Production Growth Rate (2019-2024)
            9.6.2 Japan Endorphins Production, Revenue, Price and Gross Margin (2019-2024)
      9.7 China Endorphins Production (2019-2024)
            9.7.1 China Endorphins Production Growth Rate (2019-2024)
            9.7.2 China Endorphins Production, Revenue, Price and Gross Margin (2019-2024)
  10 Key Companies Profile
      10.1 Assertio Therapeutics Inc.
            10.1.1 Assertio Therapeutics Inc. Endorphins Basic Information
            10.1.2 Assertio Therapeutics Inc. Endorphins Product Overview
            10.1.3 Assertio Therapeutics Inc. Endorphins Product Market Performance
            10.1.4 Assertio Therapeutics Inc. Business Overview
            10.1.5 Assertio Therapeutics Inc. Endorphins SWOT Analysis
            10.1.6 Assertio Therapeutics Inc. Recent Developments
      10.2 Cipher Pharmaceuticals Inc.
            10.2.1 Cipher Pharmaceuticals Inc. Endorphins Basic Information
            10.2.2 Cipher Pharmaceuticals Inc. Endorphins Product Overview
            10.2.3 Cipher Pharmaceuticals Inc. Endorphins Product Market Performance
            10.2.4 Cipher Pharmaceuticals Inc. Business Overview
            10.2.5 Cipher Pharmaceuticals Inc. Endorphins SWOT Analysis
            10.2.6 Cipher Pharmaceuticals Inc. Recent Developments
      10.3 Endo International Plc
            10.3.1 Endo International Plc Endorphins Basic Information
            10.3.2 Endo International Plc Endorphins Product Overview
            10.3.3 Endo International Plc Endorphins Product Market Performance
            10.3.4 Endo International Plc Endorphins SWOT Analysis
            10.3.5 Endo International Plc Business Overview
            10.3.6 Endo International Plc Recent Developments
      10.4 Egalet Corp.
            10.4.1 Egalet Corp. Endorphins Basic Information
            10.4.2 Egalet Corp. Endorphins Product Overview
            10.4.3 Egalet Corp. Endorphins Product Market Performance
            10.4.4 Egalet Corp. Business Overview
            10.4.5 Egalet Corp. Recent Developments
      10.5 Lannett Co. Inc.
            10.5.1 Lannett Co. Inc. Endorphins Basic Information
            10.5.2 Lannett Co. Inc. Endorphins Product Overview
            10.5.3 Lannett Co. Inc. Endorphins Product Market Performance
            10.5.4 Lannett Co. Inc. Business Overview
            10.5.5 Lannett Co. Inc. Recent Developments
      10.6 Pfizer
            10.6.1 Pfizer Endorphins Basic Information
            10.6.2 Pfizer Endorphins Product Overview
            10.6.3 Pfizer Endorphins Product Market Performance
            10.6.4 Pfizer Business Overview
            10.6.5 Pfizer Recent Developments
      10.7 Johnson and Johnson
            10.7.1 Johnson and Johnson Endorphins Basic Information
            10.7.2 Johnson and Johnson Endorphins Product Overview
            10.7.3 Johnson and Johnson Endorphins Product Market Performance
            10.7.4 Johnson and Johnson Business Overview
            10.7.5 Johnson and Johnson Recent Developments
  11 Endorphins Market Forecast by Region
      11.1 Global Endorphins Market Size Forecast
      11.2 Global Endorphins Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Endorphins Market Size Forecast by Country
            11.2.3 Asia Pacific Endorphins Market Size Forecast by Region
            11.2.4 South America Endorphins Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Endorphins by Country
  12 Forecast Market by Type and by Application (2025-2032)
      12.1 Global Endorphins Market Forecast by Type (2025-2032)
            12.1.1 Global Forecasted Sales of Endorphins by Type (2025-2032)
            12.1.2 Global Endorphins Market Size Forecast by Type (2025-2032)
            12.1.3 Global Forecasted Price of Endorphins by Type (2025-2032)
      12.2 Global Endorphins Market Forecast by Application (2025-2032)
            12.2.1 Global Endorphins Sales (K MT) Forecast by Application
            12.2.2 Global Endorphins Market Size (M USD) Forecast by Application (2025-2032)
  13 Conclusion and Key Findings
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Please select License
Single User Price:$ 2800
Site License Price:$ 3600
Enterprise Price:$ 3600